Transactions

Title Vitamin Research Products
Type AAI Mandates
Category Nutritional Supplements
Subcategory Sell-side Financing
Details Advisory Associates provided business advisory services to Vitamin Research Products and Castanea Partners in Castanea's combined investment in VRP and Health Resources. Castanea Partners will combine the two businesses to create a vertically-integrated platform in the nutritional supplement industry. The consolidated company will have multiple unique brands marketed to distinct and highly loyal consumer segments.
Title I Drive Smart
Type AAI Mandates
Category Small Business
Subcategory Strategic Advisory Services
Details AAI provided strategic operational and financial advisory services to I Drive Smart, a nationally recognized driver’s education school exclusively taught by law enforcement professionals, as the company poises for regional expansion. AAI leveraged deep experience in business process optimization in helping I Drive Smart consolidate local resources as they prepare to branch out.
Title Graceway Pharmaceuticals
Type AAI Mandates
Category Pharmaceuticals
Subcategory  Acquisition and Licensing
Details AAI advised Graceway Pharmaceuticals in their acquisition of Pfizer's dermatological product portfolio. Graceway acquired two molecules for the treatment of acne and a molecule for the treatment of scar formation. Concurrent with the agreement, Pfizer agreed to offer developmental and clinical services for the molecules.
Title Cytorex Biosciences
Type AAI Mandates
Category Pharmaceuticals
Subcategory Financing
Details AAI advised Cytorex Biosciences, a pre-clinical stage biopharmaceutical company, in its $40 million seed-round financing.  Cytorex Biosciences will use the funds to complete development of its leading therapeutic candidate,Cytoreg®, through Phase II trials for the indication of malignant brain tumors.

Title Main Street Resources
Type AAI Mandates
Category Federal Contractor - Design & Manufacturing
Subcategory M&A Buy-Side
Details AAI acted as a buy-side advisor to Main Street Resources in their acquisition of Protective Armored Systems (PAS). Founded in 1993 and headquartered in Lee, MA, PAS is a specialty fabricator of ballistics glass for the government and private sectors. PAS is an expert in glass and polymer lamination, specializing in customized bullet-resistant and security glazing fabrication. Customers include government, law enforcement, architects, business and private individuals.
Title Graceway Pharmaceuticals, LLC
Type AAI Mandates
Category Pharmaceuticals
Subcategory Sell-Side Equity Financing
Details AAI provided business advisory services in developing the business model that resulted in an equity financing transaction, in the amount of $200 million, involving GTCR Golder Rauner, LLC; a private equity firm that manages more than $8 billion in equity and mezzanine capital invested in a wide range of companies and industries, and Jefferson Gregory, co-founder of King Pharmaceuticals to form Graceway Pharmaceuticals, LLC; a specialty pharmaceutical company that focuses on bringing branded prescription products to the U.S. market through acquisition, in-licensing, and product development. Subsequently, Graceway made its first acquisition by acquiring 3M's branded pharmaceutical business in the U.S., Puerto Rico, Canada and Latin America in a transaction valued at $875 million.
Title Colliers International Property Consultants, Inc. and PharmaBioSource, Inc.
Type AAI Mandates
Category Pharmaceuticals
Subcategory Divestiture Sell-Side
Details Advisory Associates acted as advisor to both Colliers International Property Consultants, Inc., a globally affiliation of independently owned commercial real estate firms totaling more than 10,000 employees and spanning the world in more than 260 offices in 57 countries; and PharmaBioSource, Inc., a pharmaceutical and biotechnology capacity, transaction and consulting service company; in a transaction valued at $100 million involving the divestiture of an operating pharmaceutical facility, which included the legacy products manufactured there and the related contract manufacturing business.
Title Citigroup, Inc.
Type AAI Mandates
Category Pharmaceuticals
Subcategory Sell-Side Debt Financing
Details Advisory Associates acted as advisor to Citigroup - Global Healthcare Group, a division of Citigroup's Global Capital Markets, in a transaction involving the placement of $400 million in convertible debt for a publicly traded pharmaceutical company.
Title Stellar Pharmaceuticals, Inc.
Type AAI Mandates
Category Pharmaceuticals
Subcategory Sell-Side Licensing
Details Advisory Associates served as the exclusive advisor to Stellar Pharmaceuticals, Inc., a company that develops high quality, cost effective proprietary products based on its core polysaccharide technology for niche, under-served markets, in a transaction involving the licensing rights and related supply agreement of its product Uracyst ®, Stellar’s novel agent for the treatment of interstitial cystitis, to Watson Pharmaceuticals, Inc.
Title PreMD, Inc.
Type AAI Mandates
Category Pharmaceuticals
Subcategory Sell-Side Licensing
Details Advisory Associates served as the exclusive advisor to PreMD, Inc., a world leader in predictive medicine, in a transaction involving the licensing rights for the U.S. marketing and distribution of its novel non-invasive skin cholesterol test, currently marketed as PREVU - that helps assess an individual’s risk of coronary heart disease, to AstraZeneca Pharmaceuticals LP.
Title PRA International, Inc. and The Emmes Corporation
Type AAI Mandates
Category Healthcare Services
Subcategory Clinical Advisory
Details Advisory Associates provided AAI Mandates services to PRA International, Inc., one of the world’s leading global clinical development organizations with more than 3000 employees worldwide, and The Emmes Corporation, a contract research organization dedicated to providing statistical and epidemiological expertise and other overall operational support services to clients engaged in clinical and biomedical research, in a transaction involving the clinical development of a novel Age related Macular Degeneration (AMD) molecule.
Title Middlebrook Pharmaceuticals, Inc. (formerly Advancis Pharmaceutical, Inc.) and Lehman Brothers, Inc.
Type AAI Mandates
Category Biotech
Subcategory Equity Financing
Details Advisory Associates provided AAI Mandates services to Lehman Brothers related to the Initial Public Offering of Advancis, a pharmaceutical company focused on developing and commercializing anti-infective drug products utilizing its proprietary, once-a-day pulsatile drug delivery technology, PULSYS.
Title Leitner Pharmaceuticals, LLC
Type AAI Mandates
Category Pharmaceuticals
Subcategory Business Advisory Buy-Side
Details Advisory Associates provides ongoing business advisory consulting and strategy assessments to Leitner Pharmaceuticals, LLC, a wholly owned subsidiary of SJ Strategic Investments, related to business development opportunities.